Institutional Ownership Ikena Oncology, Inc. (IKNA)
This table provides information about the institutional ownership of Ikena Oncology, Inc. (IKNA). We have compiled data on the 52 institutions that hold shares in the stock, with a total of 31.7 Million shares, which have been reported (via 13F filing form) to have a value of $37.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Atlas Venture Life Science Advisors, LLC
|
Feb 06, 2025 Q4 2024 |
5,018,178
shares
|
$5.92 Million
1.36% of portfolio
|
Q4 2021
New holding
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,091,118
shares
|
$4.83 Million
2.87% of portfolio
|
Q2 2024
Added 5.14%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,006,564
shares
|
$4.73 Million
0.25% of portfolio
|
Q4 2024
Reduced 15.99%
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
May 06, 2025 Q1 2025 |
3,710,803
shares
|
$4.38 Million
3.84% of portfolio
|
Q1 2025
Added 3.48%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
3,539,358
shares
|
$4.18 Million
0.16% of portfolio
|
Q4 2023
Added 11.09%
|
|
|
Omega Fund Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,249,123
shares
|
$2.65 Million
5.63% of portfolio
|
Q1 2021
New holding
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
2,180,934
shares
|
$2.57 Million
4.65% of portfolio
|
Q3 2023
Added 2.78%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,383,418
shares
|
$1.63 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.09%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
800,000
shares
|
$944,000
0.0% of portfolio
|
Q4 2024
Reduced 19.02%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
600,063
shares
|
$708,074
0.07% of portfolio
|
Q3 2024
Added 5.26%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
382,616
shares
|
$451,486
0.05% of portfolio
|
Q4 2023
Reduced 5.0%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
354,842
shares
|
$418,713
0.0% of portfolio
|
Q2 2024
Reduced 80.6%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
330,200
shares
|
$389,636
0.0% of portfolio
|
Q4 2024
Reduced 17.57%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
327,962
shares
|
$386,995
0.0% of portfolio
|
Q4 2024
Added 21.01%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
327,410
shares
|
$386,343
0.0% of portfolio
|
Q4 2024
Reduced 15.78%
|
|
|
Peapod Lane Capital LLC
Bedford Hills, NY |
Apr 30, 2025 Q1 2025 |
296,437
shares
|
$349,795
0.43% of portfolio
|
Q1 2025
Reduced 41.63%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
288,368
shares
|
$340,274
0.0% of portfolio
|
Q4 2024
Reduced 11.47%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
199,684
shares
|
$235,627
0.0% of portfolio
|
Q4 2024
Reduced 19.94%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
195,311
shares
|
$230,466
0.0% of portfolio
|
Q3 2024
Reduced 0.37%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
157,400
shares
|
$185,732
0.0% of portfolio
|
Q4 2024
Reduced 22.12%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
155,741
shares
|
$183,774
0.0% of portfolio
|
Q4 2024
Added 18244.05%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
153,800
shares
|
$181,484
0.01% of portfolio
|
Q4 2024
Reduced 2.9%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
100,778
shares
|
$118,918
0.0% of portfolio
|
Q4 2024
Reduced 35.69%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
92,153
shares
|
$108,740
0.0% of portfolio
|
Q4 2024
Added 14.69%
|
|
|
Deuterium Capital Management, LLC
|
May 08, 2025 Q1 2025 |
80,579
shares
|
$95,083
0.29% of portfolio
|
Q3 2024
Added 0.0%
|